Paradigm Capital Management, LLC/NV

Position in PFE — Pfizer Inc

CIK 1910312 RENO, NV

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$522,511

-$102,437 QoQ

Shares Held

21,699

-2.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.68%

of 13F equity value

Holder Rank

#1,724

of 2,821 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Paradigm Capital Management, LLC/NV holds $8,119,187 across 5 Drug Manufacturers - General names. PFE ranks #4 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	28,084	$3,608,794
2	JNJ	Johnson & Johnson	8,100	$2,057,157
3	AMGN	Amgen Inc	4,435	$1,606,002
4	PFE	Pfizer Inc This page	21,699	$522,511
5	NVS	Novartis AG	2,072	$324,723

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$522,511	21,699	-2.5%	Shares	Sole	2026-08-14
2026-03-31	$624,948	22,256	-0.7%	Shares	Sole	2026-05-06
2025-12-31	$557,984	22,409	-5.8%	Shares	Sole	2026-02-06
2025-09-30	$606,449	23,801	-39.4%	Shares	Sole	2025-11-06
2025-06-30	$952,510	39,295	-35.6%	Shares	Sole	2025-08-14
2025-03-31	$1,545,258	60,981	-29.2%	Shares	Sole	2025-05-14
2024-12-31	$2,283,649	86,078	-7.1%	Shares	Sole	2025-02-14
2024-09-30	$2,681,059	92,642	+68.3%	Shares	Sole	2024-11-14
2022-12-31	$2,820,147	55,038	+2.2%	Shares	Sole	2023-02-14
2022-09-30	$2,356,694	53,855	+0.3%	Shares	Sole	2022-11-14
2022-06-30	$2,816,539	53,720	-0.5%	Shares	Sole	2022-08-12
2022-03-31	$2,795,942	54,007	+0.6%	Shares	Sole	2022-05-13
2021-12-31	$3,171,162	53,703	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.